NCT00861419 2017-02-08
To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.
Amgen
Phase 1 Completed
Clinical Trials
4 trialsNCT00360867 2015-10-15
An Open Label Treatment Extension Study of AMG 706
Amgen
Phase 2 Terminated
NCT01386866 2011-07-15
Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors
Amgen
Phase 1 Completed
NCT01235416 2011-01-21
A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors
Amgen
Phase 1 Completed